News
Eli Lilly is grabbing investor attention thanks to sharp earnings and revenue growth projections, though its Zacks Rank ...
Eli Lilly stock currently trades below its 50-week average, offering a strong entry point despite continued dominance in ...
Lone Pine Capital’s Q1 2025 13F portfolio value dropped to $11.58B, with holdings reduced from 30 to 22, focusing on top tech ...
Citi stated that as the obesity space evolves from injectables to convenient orals, such as orforglipron, the emergence of a ...
The stock's fall snapped a four-day winning streak.
LifeMD is a fast-growing, profitable telehealth company with strong partnerships. Click here to read why LFMD stock is a Buy.
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
When asked today if Ireland will follow such a move, the health minister said Mounjaro, “is going through the reimbursement ...
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
Guselkumab, whether administered every 4 or 8 weeks, demonstrates “significant inhibition” of structural damage in patients ...
DelveInsight's BAFF- and APRIL-targeted Therapies Market Size, Target Population, Competitive Landscape & Market Forecast ...
Evangeline Lilly has cancelled an appearance at the Italian Global Series Festival (IGSF) for health reasons. The star, who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results